Can MMR Vaccines Defend Against SARS-CoV-2 Infection?

The Washington University School of Medicine announced on September 3, 2020, it is the clinical coordinating center for an ambitious, international clinical trial, which is the first to evaluate on a large scale whether the common MMR vaccine can protect against COVID-19.

Data from the trial sites will be compiled at University College London. Laurence Lovat, M.D., Ph.D., a professor of gastroenterology and biophotonics, is the study leader in the United Kingdom. “If we discover that the MMR vaccine can help train the body’s immune response to SARS-CoV-2 infection, then we will have something to administer very quickly while waiting for more specific vaccines and preventive therapies to be developed,”